Marcel Borgers

Corporate Officer/Principal at Université Libre de Bruxelles

84 year

Consumer Services

Health Technology

Profile

Marcel Borgers, Ph.D.
has been Chief Scientific Officer and Chairman of our Scientific Advisory Board since May 2002.
Prior to joining, from September 1969 to April 2000, Dr. Borgers was the Vice President of Life Sciences for the Janssen Research Foundation.
Dr. Borgers held the Dr. Paul Janssen Chair in Cell Biology at the University of Antwerp from 1992 to 2002.
Dr. Borgers also has served as a professor at the Faculty of Medicine and Pharmaceutical Sciences of the Free University of Brussels since 1994 and as a Professor of Cell Biology, Faculty of Medicine, University of Maastricht, the Netherlands since 1991.
He received his doctorate in sciences from the University of Paris, Faculty of Sciences.

Marcel Borgers active positions

Companies	Position	Start
Université Libre de Bruxelles	Corporate Officer/Principal	01/01/1994
Maastricht University	Corporate Officer/Principal	01/01/1991

All active positions of Marcel Borgers

Former positions of Marcel Borgers

Companies	Position	End
University of Antwerp	Corporate Officer/Principal	01/01/2002
The Janssen Research Foundation	Corporate Officer/Principal	01/04/2000
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Chief Tech/Sci/R&D Officer	-

See the detail of Marcel Borgers's experience

Training of Marcel Borgers

Université Paris 1 Panthéon-Sorbonne

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marcel Borgers's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Health Technology
The Janssen Research Foundation